Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 66, 102934
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (DST/INSPIRE/04/2018/000991, IFA18-ENG266)
This publication has 154 references indexed in Scilit:
- The Gallic Acid–Phospholipid Complex Improved the Antioxidant Potential of Gallic Acid by Enhancing Its BioavailabilityAAPS PharmSciTech, 2013
- The gastrointestinal mucus system in health and diseaseNature Reviews Gastroenterology & Hepatology, 2013
- Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisalInternational Journal of Nanomedicine, 2012
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriersAdvanced Drug Delivery Reviews, 2012
- Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug DeliveryAAPS PharmSciTech, 2010
- Nanoparticulate drug delivery systems for cancer chemotherapyMolecular Membrane Biology, 2010
- Gastrointestinal lymphatics in health and diseasePathophysiology, 2010
- Lymphatic lipid transport: sewer or subway?Trends in Endocrinology & Metabolism, 2010
- Supramolecular phospholipids–polyphenolics interactions: The PHYTOSOME® strategy to improve the bioavailability of phytochemicalsFitoterapia, 2010
- Enhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008